Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 4 studies | 47% ± 21% | |
GABAergic neuron | 3 studies | 47% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 42% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 4470.41 | 2616 / 2642 | 52% | 0.97 | 367 / 705 |
esophagus | 100% | 2098.09 | 1442 / 1445 | 32% | 0.65 | 58 / 183 |
intestine | 100% | 2353.32 | 966 / 966 | 26% | 0.42 | 137 / 527 |
lung | 99% | 2691.83 | 575 / 578 | 23% | 0.45 | 270 / 1155 |
stomach | 100% | 3097.09 | 359 / 359 | 21% | 0.39 | 61 / 286 |
bladder | 100% | 2211.24 | 21 / 21 | 14% | 0.27 | 73 / 504 |
kidney | 100% | 1807.27 | 89 / 89 | 14% | 0.23 | 125 / 901 |
ovary | 100% | 2183.62 | 180 / 180 | 14% | 0.20 | 59 / 430 |
breast | 99% | 1992.68 | 456 / 459 | 12% | 0.20 | 138 / 1118 |
pancreas | 100% | 3194.26 | 328 / 328 | 11% | 0.16 | 19 / 178 |
adrenal gland | 100% | 1677.64 | 257 / 258 | 10% | 0.13 | 23 / 230 |
uterus | 100% | 2206.76 | 170 / 170 | 8% | 0.14 | 38 / 459 |
skin | 100% | 3490.22 | 1805 / 1809 | 8% | 0.16 | 40 / 472 |
thymus | 100% | 2609.05 | 653 / 653 | 5% | 0.07 | 32 / 605 |
prostate | 100% | 2525.36 | 245 / 245 | 5% | 0.06 | 23 / 502 |
spleen | 100% | 3184.33 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1935.96 | 1330 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 1586.00 | 1189 / 1204 | 0% | 0 | 0 / 0 |
heart | 84% | 1104.51 | 722 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 68% | 1936.97 | 634 / 929 | 0% | 0 | 0 / 0 |
liver | 27% | 314.53 | 61 / 226 | 1% | 0.02 | 6 / 406 |
muscle | 13% | 205.98 | 108 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.13 | 3 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042149 | Biological process | cellular response to glucose starvation |
GO_0045931 | Biological process | positive regulation of mitotic cell cycle |
GO_0006529 | Biological process | asparagine biosynthetic process |
GO_0006541 | Biological process | glutamine metabolic process |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0070981 | Biological process | L-asparagine biosynthetic process |
GO_0005829 | Cellular component | cytosol |
GO_0004066 | Molecular function | asparagine synthase (glutamine-hydrolyzing) activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | ASNS |
Protein name | Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Glutamine-dependent asparagine synthetase) Asparagine synthetase (glutamine-hydrolyzing) Glutamine-dependent asparagine synthetase ASNS protein Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Cell cycle control protein TS11) (Glutamine-dependent asparagine synthetase) |
Synonyms | TS11 |
Description | |
Accessions | ENST00000453600.5 C9J057 ENST00000394309.7 [P08243-1] C9JT45 P08243 ENST00000448127.1 ENST00000422745.5 [P08243-2] ENST00000442734.5 ENST00000394308.8 [P08243-1] F8WEJ5 ENST00000414884.1 ENST00000455086.5 [P08243-3] ENST00000454046.5 C9JM09 V9GZN1 C9J605 ENST00000175506.8 [P08243-1] ENST00000444334.5 [P08243-2] ENST00000451771.5 ENST00000437628.5 [P08243-3] C9JLA3 ENST00000437657.5 C9JLN6 |